Turn Therapeutics TTRX
NASDAQ TTRX
$10.58 +0.11 (+1.05%)
As of: Oct 21, 2026 · 12:49 PM EDT

Turn Therapeutics (TTRX) Payables (2024 - 2026)

Updated

Turn Therapeutics' Payables was $2.61 million in Q2 2026, up 12.5% from the prior quarter.

Analysis

Turn Therapeutics (TTRX) Payables (2024 - 2026) Analysis & Trends

At the end of FY2025, Payables at Turn Therapeutics came in at $2.93 million, up 338.9% from FY2024.

  • In earlier years, Payables was $667,272 in FY2024.
  • Quarterly Payables has moved between $667,272 (Q4 2024) and $2.93 million (Q4 2025) over five years.
  • Per Business Quant data, TTRX's Payables in the three quarters before Q2 2026 was $2.32 million (Q1 2026), $2.93 million (Q4 2025) and $2.26 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,133.15 Bn 1,101.73 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 616.41 Bn 534.94 Bn 17.26 Bn 20.92 Bn
3 AbbVie 501.01 Bn 474.12 Bn 12.70 Bn 33.30 Bn
4 Merck 367.15 Bn 321.53 Bn 12.21 Bn 5.96 Bn
5 Novartis Ag 298.00 Bn 261.99 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 261.56 Bn 235.25 Bn 12.86 Bn 22.89 Bn
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 190.38 Bn 164.57 Bn 6.22 Bn 674.00 Mn
9 Pfizer 169.76 Bn 116.40 Bn 10.94 Bn 7.03 Bn
10 Turn Therapeutics 315.16 Mn 288.27 Mn - 2.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.61 Mn
Mar 31, 2026 2.32 Mn
Dec 31, 2025 2.93 Mn
Sep 30, 2025 2.26 Mn
Dec 31, 2024 667,272.00
API Access

Turn Therapeutics Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=TTRX&period=max&api_key=YOUR_API_KEY